NVNO - enVVeno Medical Corp

📈 Is growth accelerating? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Dec 31, 2016 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Revenue Growth YoY (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	N/M	—	N/M	0.6% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-93%)	-82.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1133%)	49.4% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+518%)	114.9% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1336%)	—	—	—	—	—	—
EPS Growth YoY (%)	-1527.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-2577.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	25.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	34.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-6.5% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	29.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-13512.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	22.2% Good ↓ Good Declining Year-over-year change in earnings per share Optimal: > 10%	46.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	45.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	41.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	16.7% Good ↓ Good Declining Year-over-year change in earnings per share Optimal: > 10%	7.9% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	—	41.5% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	46.2% Excellent ↑ Excellent Improving Year-over-year change in net income	14.5% Fair ↑ Fair Improving Year-over-year change in net income	40.0% Excellent ↑ Excellent Improving Year-over-year change in net income	19.5% Good ↑ Good Improving Year-over-year change in net income	-35.1% Weak ↓ Weak Declining Year-over-year change in net income	9.8% Fair ↑ Fair Improving Year-over-year change in net income	-10.3% Weak ↓ Weak Declining Year-over-year change in net income	-12.8% Weak ↓ Weak Declining Year-over-year change in net income	23.4% Good ↑ Good Improving Year-over-year change in net income	21.9% Good ↑ Good Improving Year-over-year change in net income	8.6% Fair ↑ Fair Improving Year-over-year change in net income	6.2% Fair ↑ Fair Improving Year-over-year change in net income	-21.5% Weak ↑ Weak Improving Year-over-year change in net income	-19.9% Weak ↑ Weak Improving Year-over-year change in net income	31.2% Excellent ↑ Excellent Improving Year-over-year change in net income	-92.2% Weak → Weak Stable Year-over-year change in net income	-92.2% Weak ↑ Weak Improving Year-over-year change in net income	-92.2% Weak ↑ Weak Improving Year-over-year change in net income	-105.5% Weak ↑ Weak Improving Year-over-year change in net income	-139.1% Weak ↓ Weak Declining Year-over-year change in net income	-139.1% Weak ↓ Weak Declining Year-over-year change in net income	-139.1% Weak ↓ Weak Declining Year-over-year change in net income	-90.9% Weak ↓ Weak Declining Year-over-year change in net income	26.3% Excellent ↑ Excellent Improving Year-over-year change in net income	26.3% Excellent ↑ Excellent Improving Year-over-year change in net income	26.3% Excellent ↓ Excellent Declining Year-over-year change in net income	-28.6% Weak ↓ Weak Declining Year-over-year change in net income	66.9% Excellent ↑ Excellent Improving Year-over-year change in net income	66.9% Excellent ↑ Excellent Improving Year-over-year change in net income	66.9% Excellent ↑ Excellent Improving Year-over-year change in net income	43.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-110.5% Weak Weak Year-over-year change in net income	-280.1% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	—	-2407.8% Weak Weak Year-over-year change in free cash flow	—	—	—	10.9% Fair Fair Year-over-year change in free cash flow	—	—	—	51.3% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Dec 31, 2016 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
FCF / Net Income (x)	0.99x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.97x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.89x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.71x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.80x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.63x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.64x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.35x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	1.39x Good → Good Stable Free cash flow relative to reported net income Optimal: > 1x	0.60x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	2.26x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.24x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.00x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.71x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	—	1.02x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.37x Weak → Weak Stable Free cash flow relative to reported net income Optimal: > 1x	0.32x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.34x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.41x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.54x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Dec 31, 2016 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Return on Invested Capital (%)	-14.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.5% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-11.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-13.1% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-16.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-12.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.3% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-11.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-17.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.4% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-11.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-4.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-5.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-46.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-31.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-330.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	8149.7% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-183.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-47.0% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-33.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-43.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-69.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-33.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-53.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	7.3% Fair Fair Return earned on debt + equity capital invested Optimal: > 10%	13.7% Good Good Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—
Return on Capital (%) (%)	-16.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-15.6% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-13.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-15.1% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-19.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-14.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.2% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-13.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-12.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-12.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-19.0% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-21.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-18.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-15.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-13.5% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-14.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-15.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-4.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-5.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-6.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-39.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-54.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-66.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-31.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-28.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	-50.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-87.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-17.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-216%)	-16.2% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-208%)	-13.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-192%)	-15.4% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-203%)	-20.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-235%)	-11.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-178%)	-14.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-199%)	-11.9% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-179%)	-12.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-186%)	-11.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-179%)	-12.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-182%)	-20.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-234%)	-22.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-250%)	-18.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-225%)	-16.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-206%)	-12.5% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-183%)	-11.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-176%)	-10.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-169%)	-16.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-210%)	-4.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-132%)	-6.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-145%)	-6.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-143%)	-61.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-511%)	-24.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-261%)	—	—	-231.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1643%)	-51.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-440%)	-33.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-326%)	-54.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-466%)	-87.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-683%)	-134.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-993%)	-103.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-786%)	30.2% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+101%)	28.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+87%)	—	—	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Dec 31, 2016 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	—	—	—	-174.72x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-151.04x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	-246.04x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	-1067.00x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-355.99x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-949.05x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-3408.31x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-6780.30x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-572.93x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	-84.88x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-194.05x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-127.19x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-84.64x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-3192.38x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-901.44x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-4.79x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-18.65x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-28.66x Weak Weak Operating income divided by interest expense Optimal: > 5x	-199.83x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—
Net Debt (USD)	$-2.84M	$-2.60M	$-3.06M	$-1.54M	$-2.04M	$-2.94M	$-1.75M	$-17.91M	$-2.38M	$-2.31M	$-3.62M	$-4.95M	$-4.71M	$-2.27M	$-4.55M	$-2.90M	$-9.07M	$-51.34M	$-54.73M	$-57.90M	$-41.04M	$-43.84M	$-9.33M	—	—	$-720.13K	$-1.31M	$-2.94M	$-4.47M	$-2.75M	$-2.74M	—	—	$-309.13K	$-77.69K	$-311.48K	—	$-56.51K	$-56.51K

📊 What does each share earn? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Dec 31, 2016 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Basic EPS, GAAP (USD)	$-5.37	$-5.89	$-32.28	$-0.23	$-0.33	$-0.22	$-43.56	$-0.35	$-0.31	$-0.31	$-0.32	$-0.45	$-0.58	$-0.57	$-0.55	$-0.54	$-0.63	—	$-0.94	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-5.29	$-4.95	—	$-0.22	—	$-0.20	—	—	—	$-0.22	—	—	—	$-0.46	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$30.71	$36.20	$41.36	$1.46	$1.72	$2.18	$84.15	$2.70	$2.88	$3.18	$3.47	$2.63	$3.04	$3.60	$4.09	$4.50	$4.92	$5.42	$5.74	$6.13	$4.80	$5.06	$2.79	—	—	$-0.00	$1.38	$0.17	—	$0.20	$0.17	—	—	—	$-1.81	—	—	—	—
Tangible Book Value per Share (USD)	$30.71	$36.20	$41.36	$1.46	$1.72	$2.18	$84.15	$2.70	$2.88	$3.18	$3.47	$2.63	$3.04	$3.60	$4.09	$4.50	$4.92	$5.42	$5.74	$6.13	$4.80	$5.06	$2.79	—	—	$-0.00	$1.38	$0.14	—	$0.20	$0.12	—	—	—	$-1.81	—	—	—	—
Basic Weighted Avg Shares (shares)	671,000	654,000	—	20.16M	20.35M	20.35M	—	16.07M	16.07M	16.06M	—	11.23M	11.23M	11.23M	—	11.23M	11,229	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Dec 31, 2016 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Working Capital (USD)	$20.20M	$23.35M	$26.70M	$29.10M	$32.59M	$37.82M	$41.64M	$46.82M	$37.84M	$41.76M	$45.55M	$24.19M	$28.04M	$33.35M	$37.91M	$39.40M	$35.94M	$50.38M	$53.46M	$57.09M	$40.05M	$42.29M	$6.38M	—	—	$-1.41M	$-452.43K	$1.04M	—	$1.11M	$1.31M	—	—	—	—	—	—	—	—
Total Equity (USD)	$20.67M	$23.75M	$27.13M	$29.45M	$33.06M	$38.31M	$42.16M	$47.37M	$38.42M	$42.37M	$46.20M	$24.91M	$28.81M	$34.13M	$38.73M	$42.67M	$46.56M	$51.32M	$54.40M	$58.05M	$40.87M	$43.01M	$7.10M	$4.79M	$369.45K	$-14.62K	$989.94K	$3.08M	$4.65M	$2.87M	$2.04M	$3.54M	$4.61M	$-15.74M	$-11.13M	—	—	—	$-4.22M

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Dec 31, 2016 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$0.00	—	$0.00	$31.24K	$30.46K	$41.66K	$83.36K	$31.07K	$175.12K	$27.88K	$38.80K	—	—
Depreciation Expense (USD)	—	—	—	—	—	$100.00K	—	—	—	$100.00K	—	—	—	$100.00K	—	—	—	$100.00K	$55.92K	$-14.98K	$-40.94K	$27.62K	$33.14K	$21.90K	$25.29K	$19.68K	$19.19K	—	$8.08K	$3.06K	$2.80K	$2.55K	$2.38K	$2.38K	—	—	—	—	—
Net Income, GAAP (USD)	$-3.60M	$-3.85M	$-3.74M	$-4.54M	$-6.69M	$-4.50M	$-6.23M	$-5.64M	$-4.96M	$-4.99M	$-5.65M	$-5.00M	$-6.47M	$-6.39M	$-6.18M	$-5.33M	$-5.33M	$-5.33M	$-8.99M	$-2.77M	$-2.77M	$-2.77M	$-4.37M	$-1.16M	$-1.16M	$-1.16M	$-2.29M	$-1.57M	$-1.57M	$-1.57M	$-1.78M	$-4.75M	$-4.75M	$-4.75M	$-3.12M	$-2.25M	$-1.25M	—	—
Operating Cash Flow (USD)	$-3.55M	$-3.24M	$-3.44M	$-4.39M	—	$-4.02M	$-5.11M	—	—	$-3.55M	$-4.97M	—	—	$-5.11M	$-3.86M	—	—	$-3.32M	$-3.10M	—	—	$-3.84M	$-2.61M	$-2.59M	$-1.32M	$-1.15M	$-1.62M	—	$-1.43M	$-1.49M	$-1.44M	$-1.74M	$-1.54M	$-1.63M	$-1.27M	$-1.21M	—	—	—

enVVeno Medical Corp

Analytical Summary

39-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare NVNO with peers